Showing results (31-40 of 206) with videos related to
Sort By:
Pageof 21
Autoimmunity Reviews|April 9, 2026
Anti-CD52 therapy of rheumatic diseases: Revisited in the era of immune resetFadi Hassan, John D Isaacs, Mohammad E NaffaaNature Reviews. Rheumatology|November 5, 2016
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkersPhilip M Brown, Arthur G Pratt, John D IsaacsNature Reviews. Rheumatology|December 15, 2015
Cytokines in rheumatoid arthritis - shaping the immunological landscapeIain B McInnes, Christopher D Buckley, John D IsaacsBest Practice & Research. Clinical Rheumatology|February 24, 2009
Current concepts in the pathogenesis of early rheumatoid arthritisArthur G Pratt, John D Isaacs, Derek L MatteyExpert Opinion on Investigational Drugs|September 1, 2009
Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?Robert J Moots, Andrew Jk Ostör, John D IsaacsExpert Review of Clinical Immunology|May 28, 2020
In search of pathobiological endotypes: a systems approach to early rheumatoid arthritisJessica R Tarn, Dennis W Lendrem, John D IsaacsCurrent Rheumatology Reports|July 27, 2013
Treg cells in rheumatoid arthritis: an updateFaye A H Cooles, John D Isaacs, Amy E AndersonInternational Reviews of Immunology|March 5, 2010
Development of dendritic cell-based immunotherapy for autoimmunityCatharien M U Hilkens, John D Isaacs, Angus W ThomsonThe Lancet. Rheumatology|January 27, 2024
Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?Kenneth F Baker, Jasmine P X Sim, John D IsaacsBMC Cancer|June 14, 2024
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort studyAbigail Gault, Linda Hogarth, Kristian C Williams, et al.Pageof 21